您当前的位置：
首页 >
文章列表页 >
Molecular Mechanism of Gypenoside L Inducing Ovarian Cancer Cell Apoptosis by Regulating NUF2 and Influencing Magnesium Homeostasis
更新时间：2026-05-29

    • Molecular Mechanism of Gypenoside L Inducing Ovarian Cancer Cell Apoptosis by Regulating NUF2 and Influencing Magnesium Homeostasis

      增强出版
    • Chinese Journal of Experimental Traditional Medical Formulae   Vol. 32, Issue 13, Pages: 155-165(2026)

    • DOI：10.13422/j.cnki.syfjx.20260611    

      CLC： R711;R285;R289

    • Received：09 February 2026，

      Revised：2026-04-07，

      Accepted：21 April 2026，

      Online First：26 April 2026，

      Published：05 July 2026

    移动端阅览

  • HONG Yang,ZHANG Di,DONG Yuanguang,et al.Molecular Mechanism of Gypenoside L Inducing Ovarian Cancer Cell Apoptosis by Regulating NUF2 and Influencing Magnesium Homeostasis[J].Chinese Journal of Experimental Traditional Medical Formulae,2026,32(13):155-165. DOI： 10.13422/j.cnki.syfjx.20260611.

  •  
  •  

0

Views

8

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Gypenoside L Regulates piR-hsa-2804461/FKBP8/Bcl-2 Axis to Promote Apoptosis and Inhibit Ovarian Cancer
Exploring Molecular Mechanism of Gypenoside L against Ovarian Cancer Based on Ferroptosis Pathway Mediated by Mature-tRNA-Asp-GTC/ATF3-LPCAT3
Molecular Mechanism of Treating Different Diseases with Same Treatment of Gypenoside L Affecting Oxidative Damage HUVEC and OVCAR-3 Through EGFR/STAT3/Glycolytic Pathway
Molecular Mechanism of Gypenoside L in Anti-Ovarian Cancer by Affecting GCK-Mediated Glycolytic Pathway
Traditional Chinese Medicine Treatment of Colorectal Cancer Based on AMPK Signaling Pathway： A Review

Related Author

DONG Yuanguang
SUN Yinying
YUAN Mingdian
YANG Ying
WANG Jiaxin
ZHU Jingxuan
SONG Nan
ZHU Jingxuan

Related Institution

Liaoning Provincial Hospital of TCM
Liaoning University of Traditional Chinese Medicine
Liaoning Cancer Hospital & Institute
Shenyang He's Eye Hospital Co. Ltd.
Liaoning Cancer Hospital
0